Kayyem Jon Faiz Insider Trades & Stock Holdings

Director · Inhibrx Biosciences, Inc. · Latest filing Sep 23, 2026

Kayyem Jon Faiz, Director at Inhibrx Biosciences, Inc. has 1 Form 4 trade on file since Sep 23, 2026. Open-market activity: 1 purchase ($500K) and 0 sales ($0), net +$500K. Latest filing: acquired 5K shares of $INBX on Sep 23, 2026 at $100.

Trades on file

1

Open-market bought

$500K

Open-market sold

$0

Net open-market

+$500K

Latest filing

Sep 23, 2026

All insider trades by Kayyem Jon Faiz

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 23, 2026	$INBX	Buy (Open-market buy)	5K	$100	$500K			-0.2%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kayyem Jon Faiz traded

• $INBX

Frequently asked questions

Has Kayyem Jon Faiz been buying or selling stock?

Kayyem Jon Faiz has 1 open-market purchase and 0 open-market sales on file, net +$500K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kayyem Jon Faiz's latest insider trade?

acquired 5K shares of $INBX on Sep 23, 2026 at $100.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.